Clinical Trial: To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07208591) titled 'To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome' on Sept. 28.

Brief Summary: To evaluate the efficacy, safety and tolerability of STSA-1002 injection in patients with acute respiratory distress syndrome

Study Start Date: Oct., 2025

Study Type: INTERVENTIONAL

Condition: Acute Respiratory Distress Syndrome (ARDS)

Intervention: DRUG: STSA-1002 injection

basal treatment + STASA-1002 intravenous infusion

DRUG: STSA-1002 Injection Placebo

basal treatment + STSA-1002 Injection Placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Staidson (Beijing) Biopharmaceutica...